Recent advances in the diagnosis and management of amoebiasis

Joseph Cooney; Spyros I. Siakavellas; Peter L. Chiodini; Ula Mahadeva; Gauri Godbole; Richard C.G. Pollok; Philip J. Smith

doi:10.1136/flgastro-2023-102554

Recent advances in the diagnosis and management of amoebiasis

Joseph Cooney, Spyros I. Siakavellas, Peter L. Chiodini, Ula Mahadeva, Gauri Godbole, Richard C.G. Pollok^*, Philip J. Smith

^*Corresponding author for this work

Gastrointestinal Infections

Research output: Contribution to journal › Review article › peer-review

Abstract

With increasing international travel and migration, tropical and infectious diseases once largely confined to specialist institutes now present more widely. Amoebiasis is a potentially dangerous example since it may closely mimic the presentation of inflammatory bowel disease. Misdiagnosis and treatment with immunosuppressants can result in fulminant amoebiasis and death. This review considers the epidemiology, pathogenesis, clinical features, diagnosis and treatment of intestinal and extraintestinal amoebiasis. It is written primarily for gastroenterologists, surgeons and acute physicians.

Original language	English
Journal	Frontline Gastroenterology
DOIs	https://doi.org/10.1136/flgastro-2023-102554
Publication status	Accepted/In press - 2024

Bibliographical note

Publisher Copyright:
© Author(s) (or their employer(s)) 2024.

Keywords

DIARRHOEA
IBD
INFECTIVE COLITIS

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1136/flgastro-2023-102554

Cite this

@article{254700c25b064eee8eb0481ffd3a3394,

title = "Recent advances in the diagnosis and management of amoebiasis",

abstract = "With increasing international travel and migration, tropical and infectious diseases once largely confined to specialist institutes now present more widely. Amoebiasis is a potentially dangerous example since it may closely mimic the presentation of inflammatory bowel disease. Misdiagnosis and treatment with immunosuppressants can result in fulminant amoebiasis and death. This review considers the epidemiology, pathogenesis, clinical features, diagnosis and treatment of intestinal and extraintestinal amoebiasis. It is written primarily for gastroenterologists, surgeons and acute physicians.",

keywords = "DIARRHOEA, IBD, INFECTIVE COLITIS",

author = "Joseph Cooney and Siakavellas, {Spyros I.} and Chiodini, {Peter L.} and Ula Mahadeva and Gauri Godbole and Pollok, {Richard C.G.} and Smith, {Philip J.}",

note = "Publisher Copyright: {\textcopyright} Author(s) (or their employer(s)) 2024.",

year = "2024",

doi = "10.1136/flgastro-2023-102554",

language = "English",

journal = "Frontline Gastroenterology",

issn = "2041-4137",

publisher = "BMJ Publishing Group",

}

TY - JOUR

T1 - Recent advances in the diagnosis and management of amoebiasis

AU - Cooney, Joseph

AU - Siakavellas, Spyros I.

AU - Chiodini, Peter L.

AU - Mahadeva, Ula

AU - Godbole, Gauri

AU - Pollok, Richard C.G.

AU - Smith, Philip J.

PY - 2024

Y1 - 2024

N2 - With increasing international travel and migration, tropical and infectious diseases once largely confined to specialist institutes now present more widely. Amoebiasis is a potentially dangerous example since it may closely mimic the presentation of inflammatory bowel disease. Misdiagnosis and treatment with immunosuppressants can result in fulminant amoebiasis and death. This review considers the epidemiology, pathogenesis, clinical features, diagnosis and treatment of intestinal and extraintestinal amoebiasis. It is written primarily for gastroenterologists, surgeons and acute physicians.

AB - With increasing international travel and migration, tropical and infectious diseases once largely confined to specialist institutes now present more widely. Amoebiasis is a potentially dangerous example since it may closely mimic the presentation of inflammatory bowel disease. Misdiagnosis and treatment with immunosuppressants can result in fulminant amoebiasis and death. This review considers the epidemiology, pathogenesis, clinical features, diagnosis and treatment of intestinal and extraintestinal amoebiasis. It is written primarily for gastroenterologists, surgeons and acute physicians.

KW - DIARRHOEA

KW - IBD

KW - INFECTIVE COLITIS

UR - http://www.scopus.com/inward/record.url?scp=85207708396&partnerID=8YFLogxK

U2 - 10.1136/flgastro-2023-102554

DO - 10.1136/flgastro-2023-102554

M3 - Review article

AN - SCOPUS:85207708396

SN - 2041-4137

JO - Frontline Gastroenterology

JF - Frontline Gastroenterology

ER -

Recent advances in the diagnosis and management of amoebiasis

Abstract

Bibliographical note

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this